In response to the need for more information about the use and outcomes of interventional procedures for the treatment of endovascular therapy patients, the NCDR launched the
Peripheral Vascular Intervention (PVI) Registry earlier this year. This much anticipated registry drives quality improvement at the institutional level, allows for broader dissemination of best practices and serves as a basis for valuable comparative effectiveness research.
The PVI Registry, which replaces and expands upon the CARE Registry, addresses the transition in cardiovascular care from an open surgical model to a percutaneous model for treatment of peripheral vascular disease (PVD). Recognizing that little is known about the use and outcomes of angiography and interventional procedures, the NCDR designed the PVI Registry to assess the prevalence, demographics, management and outcomes of patients undergoing percutaneous treatment for PVD. The registry continues to offer data collection for carotid artery stenting (CAS) and carotid endarterectomy procedures (CEA), but now incorporates lower extremity peripheral arterial catheterbased procedures for more complete reporting on PVD treatments.
Like other NCDR registries, the PVI Registry provides physicians and hospitals with quarterly risk-adjusted benchmark reports and executive summary dashboards that allow for detailed comparisons-offering important data on endovascular technologies and treatments, benchmarked against national standards. The registry captures patient demographics, provider and facility characteristics, comparisons for highrisk surgical patients treated with CAS versus CEA, the use of balloons, stents and embolic protection devices, adverse event rates and 30-day follow-up data. In addition to the hospital cardiac cath lab, the registry can be used in interventional radiology suites, hybrid operating rooms or outpatient vascular centers capturing data on a larger number of PVI procedures across disciplines and offering quality improvement in those settings.
In addition to adding peripheral intervention modules, another goal of the registry is to assist with the monitoring of different treatments across specialties in order to understand how different training and techniques affect patient outcomes. This is also a major driving factor in the creation of the new
Diabetes Collaborative Registry. A partnership between the American College of Cardiology, the American Diabetes Association, the American College of Physicians and the Joslin Diabetes Center, the Diabetes Collaborative Registry, is the first clinical registry aimed at tracking and improving the quality of diabetes and cardiometabolic care across the primary and specialty care continuum. Made possible through support from founding sponsor AstraZeneca, the registry will leverage the
PINNACLE Registry's already well-established technology platform to retrieve data from electronic medical records collected by participating primary care physicians, endocrinologists, cardiologists and other diabetes
care providers.
More information about the Diabetes Collaborative Registry will follow in the coming months. To learn more about the NCDR, visit
NCDR.com.